Phase I/II Study of Ruxolitinib (RUX) with Decitabine (DAC) in Patients with Post-Myeloproliferative Neoplasm Acute Myeloid Leukemia (post-MPN AML): Phase I Results
Year: 2016
Type: article
Study design: Clinical Trial
Source: Blood
Authors: Prithviraj Bose, Srdan Verstovsek, Yvonne Gasior, Nitin Jain, Elias J. Jabbour, Zeev Estrov, Yesid Alvarado, Courtney D. DiNardo, Naveen Pemmaraju, Steven M. Kornblau, Tapan M. Kadia, Naval G. Daver, Mark Brandt, Sherry Pierce, Graciela M. Nogueras-Gonzalez, Xuelin Huang, Guillermo Garcia-Manero, Hagop M. Kantarjian, Farhad Ravandi
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2608154444